$VIVS Income Statement | Understand Stock

$VIVS

$0.15 +$0.00 (2.36%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2026 12 months to Mar 31, 2026	FY2025 12 months to Mar 31, 2025	FY2024 12 months to Mar 31, 2024	FY2023 12 months to Mar 31, 2023	FY2022 12 months to Mar 31, 2022
Cost of revenues
Research and development expenses
Selling, general, and administrative expenses
Total costs and expenses
Loss from Operations
Other Income (Expense)
Loss on issuance of common stock
Gain on investment in equity securities
Gain on sale of asset
Interest income
Other income
Interest expense
Total Other Income (Expense)

Income Tax Expense
Net Loss
Net loss per common share—basic and diluted
Weighted average shares used in computing net loss per common share—basic and diluted
Unrealized loss on available-for-sale debt securities
Comprehensive Loss
Net loss per common share basic
Net loss per common share diluted
Weighted average shares used in computing net loss per common share basic
Weighted average shares used in computing net loss per common share diluted

Comments